Quidel stock forecast as shares spike 6% on increased Omicron testing needs

By: Motiur Rahman
Motiur Rahman
Md Motiur enjoys researching how companies are solving challenges the world will face over the coming decades. In his… read more.
on Dec 31, 2021
  • Quidel shares are up more than 6% since Wednesday.
  • The company said its diagnostics kits could detect Omicron.
  • The government is encouraging more tests to help stem the spread of the virus.

On Thursday, Quidel Corp (NASDAQ:QDEL) shares gained nearly 4%, extending Wednesday’s gains to over 6%. The stock has been on an upward trajectory since revealing its covid-testing kit could detect the Omicron variant. The US government is asking for more at-home testing to help mitigate the highly transmissible version.

However, the FDA has warned that, although Covid antigen tests can detect the Omicron variant, there may also be some false negatives. However, that has not stopped home-based covid testing kit providers from surging amid the increasing spread of the pandemic.

Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.

Cue Health Inc. (NASDAQ:HLTH) and Lucira Health Inc. (NASDAQ:LHDX) have spiked since Christmas week, rallying more than 15% each, before pulling back recently.

Is it safe to buy Quidel shares?

Although Quidel stock has bounced back in the last two days, the stock is still down more than 23% since spiking more than 30% between the 10th and 20th of December.

As a result, the stock has plummeted to trade at an attractive forward P/E ratio of 6.52, making it a compelling option for value investors.

In addition, analysts expect its EPS to grow by more than 970% this year before rising at an average annual rate of about 7.2% over the next five years.

Therefore, growth investors could also be interested.

Source – TradingView

Technically, Quidel shares seem to be trading within a sharply descending channel formation in the intraday chart. However, the stock recently bounced back, creating an opportunity to buy.

Therefore, investors could target extended gains at about $138.81, or higher at $144.97, while $126.50 and $119.81 are crucial support zones.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

  1. Etoro, trusted by over 13m users worldwide. Register here >
  2. Capital.com, simple, easy to use and regulated. Register here >

*Cryptoasset investing is unregulated in some EU countries and the UK. No consumer protection. Your capital is at risk.